iShares Biotechnology ETF logo

iShares Biotechnology ETF (IBB)

Market Closed
3 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
130. 00
+0.45
+0.35%
After Hours
$
126. 53
-3.47 -2.67%
8.81B Market Cap
0.5% Div Yield
659,000 Volume
$ 129.55
Previous Close
Day Range
129.21 130.29
Year Range
107.43 150.57
Want to track IBB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
iShares Biotechnology ETF: Playing Defense

iShares Biotechnology ETF: Playing Defense

The biotech sector is very defensive and non-cyclical due to the necessity of medications and healthcare treatment being largely independent of economic growth and market risk sentiment. Money is returning to the biotech sector as displayed by increased M&A activity and financing following the pandemic-driven bubble in the sector. Biotech is a blooming area of innovation and US productivity and is expected to grow at a 14% CAGR over the next decade.

Seekingalpha | 6 months ago
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

The iShares Biotechnology ETF (IBB) made its debut on 02/05/2001, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.

Zacks | 7 months ago
Should You Invest in the iShares Biotechnology ETF (IBB)?

Should You Invest in the iShares Biotechnology ETF (IBB)?

Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund launched on 02/05/2001.

Zacks | 7 months ago
Is Biotech's Bull Run Over? Examining Election Impacts

Is Biotech's Bull Run Over? Examining Election Impacts

The biotech sector recently experienced a sharp reversal following a failed breakout attempt post-election. While most areas of the market surged to new heights after Donald Trump's election win on November 5, biotech ETFs like the iShares Biotechnology ETF NASDAQ: IBB and the SPDR Biotech ETF NYSE: XBI stopped short of new 52-week highs.

Marketbeat | 7 months ago
Final Trade: Euro, IBB, SMH, NEM

Final Trade: Euro, IBB, SMH, NEM

The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.

Youtube | 7 months ago
IBB: A Near-20x P/E Is Historically Pricey, Technical Trends Neutral

IBB: A Near-20x P/E Is Historically Pricey, Technical Trends Neutral

I reiterate a hold rating on IBB due to its stretched valuation at nearly 20x earnings and mixed technical situation. Despite a 7% YTD gain, IBB has underperformed the S&P 500, which is up 21%, and shows negative alpha. Key support and resistance levels to watch are $138-$141 and $150, respectively, with a potential bullish move to $160.

Seekingalpha | 8 months ago
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

Making its debut on 02/05/2001, smart beta exchange traded fund iShares Biotechnology ETF (IBB) provides investors broad exposure to the Health Care ETFs category of the market.

Zacks | 9 months ago
Should You Invest in the iShares Biotechnology ETF (IBB)?

Should You Invest in the iShares Biotechnology ETF (IBB)?

If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund launched on 02/05/2001.

Zacks | 9 months ago
Biotech Boom Ahead? Key Stocks and ETFs to Watch Now

Biotech Boom Ahead? Key Stocks and ETFs to Watch Now

As a new regime and phase begin for the market and economy, after the FED cut interest rates by a surprising 50bps last Wednesday, several new opportunities and sector bull and bear markets might begin.

Marketbeat | 9 months ago
Biotech Breakout: Stocks for Your Watchlist

Biotech Breakout: Stocks for Your Watchlist

After a prolonged consolidation and downtrend following the pandemic-driven surge, the biotechnology sector is readying for a potential breakout and shifting its narrative. Represented by the iShares Biotechnology ETF NASDAQ: IBB, the sector has turned a significant corner, with previous resistance levels becoming support, setting the stage for a potential momentum shift.

Marketbeat | 9 months ago
3 ETFs for Growth Investors to Buy and Hold for Decades

3 ETFs for Growth Investors to Buy and Hold for Decades

Exchange-traded funds aren't just for risk-averse investors. Many funds can give exposure to some great growth stocks.

Fool | 10 months ago
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

The iShares Biotechnology ETF (IBB) made its debut on 02/05/2001, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.

Zacks | 11 months ago
Loading...
Load More